Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2014
10/02/2014US20140296315 Pyrazole-amide compounds and pharmaceutical use thereof
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296283 Substituted 6,5-Fused Bicyclic Heteroaryl Compounds
10/02/2014US20140296238 Dihydropyrazoles
09/2014
09/30/2014US8846949 Pyrrolopyrazoles as N-type calcium channel blockers
09/30/2014US8846936 Sulfonyl compounds which modulate the CB2 receptor
09/30/2014US8846935 Indazoles
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846913 Neprilysin inhibitors
09/30/2014US8846743 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846569 Pesticidal bis-organosulfur compounds
09/30/2014US8846024 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
09/25/2014WO2014153226A1 Arginine methyltransferase inhibitors and uses thereof
09/25/2014WO2014153214A1 Arginine methyl transferase inhibtors and uses thereof
09/25/2014WO2014153172A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/25/2014WO2014153090A1 Pyrazole derivatives asprmt1 inhibitors and uses thereof
09/25/2014WO2014152588A1 Covalent inhibitors of kras g12c
09/25/2014WO2014151899A1 Polycyclic estrogen receptor modulators and uses thereof
09/25/2014US20140288141 Prmt1 inhibitors and uses thereof
09/25/2014US20140288140 Prmt1 inhibitors and uses thereof
09/25/2014US20140288129 Prmt1 inhibitors and uses thereof
09/25/2014US20140288124 Arginine methyltransferase inhibitors and uses thereof
09/25/2014US20140288090 N-arylylmethylindazole modulators of pparg
09/24/2014EP2781508A1 Nitrogen-containing fused ring compounds for use as crth2 antagonists
09/24/2014EP2780322A1 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
09/24/2014EP2780009A1 Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
09/23/2014US8841483 Compositions useful as inhibitors of voltage-gated sodium channels
09/23/2014US8841462 Bicyclic heterocycles as MEK kinase inhibitors
09/23/2014US8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors
09/23/2014US8841332 Fungicidal N-(2-phenoxyethyl)carboxamide derivatives and their aza, thia and sila analogues
09/23/2014US8841324 Heterocyclic compounds as autotaxin inhibitors
09/18/2014WO2014145040A1 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
09/18/2014WO2014144659A1 Pyrazole derivatives as prmt1 inhibitors and uses thereof
09/18/2014WO2014143666A1 Hdac inhibitors
09/18/2014WO2014142291A1 Hydrate of fluorine compound, and crystals thereof
09/18/2014WO2014142290A1 Pyrazole-amide compound and medicinal uses therefor
09/18/2014WO2014138979A1 Pyrazole derivatives and their uses thereof
09/18/2014US20140275134 Meldrum's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
09/18/2014US20140275049 SUBSTITUTED PYRAZOLE ANALOGS As RAR ANTAGONISTS
09/18/2014US20140275037 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/18/2014US20140271662 Pyrazole derivatives as protein kinase modulators
09/17/2014EP2776402A1 Meldrum 's acid, barbituric acid and pyrazolone derivatives substituted with hydroxylamine as hno donors
09/17/2014EP2776401A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an so2-containing group as vanilloid receptor ligands
09/17/2014EP2776400A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with a co-containing group as vanilloid receptor ligands
09/17/2014EP2776399A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an n-containing group as vanilloid receptor ligands
09/17/2014EP2776398A1 Substituted pyrazolyl-based carboxamide and urea derivatives bearing a phenyl moiety substituted with an o-containing group as vanilloid receptor ligands
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835481 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
09/16/2014US8835472 Compounds, pharmaceutical compositions and uses thereof
09/16/2014US8835444 Cyclohexyl amide derivatives as CRF receptor antagonists
09/16/2014US8835437 Piperidine/piperazine derivatives
09/16/2014CA2653666C Aryl-substituted heterocycles and their use
09/16/2014CA2623202C Hydrazide compound and pesticidal use of the same
09/12/2014WO2014137728A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014137725A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014137723A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014137719A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/12/2014WO2014135608A1 Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-heterocycle derivatives
09/12/2014WO2014135477A1 Fungicidal 3-{phenyl[(heterocyclylmethoxy)imino]methyl}-oxadiazolone derivatives
09/12/2014WO2014134776A1 Compounds inhibiting leucine-rich repeat kinase enzyme activity
09/11/2014US20140256780 Pyrazole derivatives as modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256771 Compounds that modulate intracellular calcium
09/11/2014US20140256744 Polycyclic compounds as lysophosphatidic acid receptor antagonists
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256727 Methods and compositions of small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/11/2014US20140256701 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/11/2014US20140256698 Cathepsin inhibitors
09/11/2014DE102013022031B3 Lösungsmittelsysteme für N-((3(5)-Methyl-1H-pyrazol-1-yl)methyl)acetamid und deren Verwendung zur Behandlung von harnstoffbasierten/ammoniumhaltigen Düngemitteln Solvent systems for N - ((3 (5) -methyl-1H-pyrazol-1-yl) methyl) acetamide, and their use for the treatment of urea-based / ammonium-containing fertilizers
09/10/2014EP2773615A1 Pharmaceutical compounds
09/10/2014EP2773613A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection
09/09/2014US8829034 Compounds which modulate the CB2 receptor
09/04/2014WO2014134391A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134388A1 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
09/04/2014WO2014134313A1 Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof
09/04/2014US20140249151 Bicyclic heterocyclic compound
09/04/2014US20140249148 Selective hdac3 inhibitors
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2772484A1 Bicyclic heterocyclic compound
09/03/2014EP2771324A1 Myxovirus therapeutics, compounds, and uses related thereto
09/02/2014US8822522 Dual-acting pyrazole antihypertensive agents
09/02/2014US8822521 Substituted benzene fungicides
09/02/2014US8822467 Biaryl oxyacetic acid compounds
09/02/2014US8822464 N-aryl-piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
08/2014
08/28/2014WO2014130947A1 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014WO2014129668A1 Production method of pyridazinone compounds
08/28/2014US20140243366 Compounds that modulate intracellular calcium
08/28/2014US20140243362 Sulfonamide compounds and their use in the modulation retinoid-related orphan receptor
08/28/2014US20140243338 Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
08/28/2014US20140243335 Substituted hydoxamic acids and uses thereof
08/28/2014US20140243310 Bicyclic compound
08/28/2014US20140243309 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
08/28/2014US20140243287 Pyrazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
08/28/2014US20140237735 Zwitterionic azo dyestuffs for colouring keratin-including fibres
08/27/2014EP2768810A1 Compounds that modulate intracellular calcium
08/26/2014US8816096 Process for preparing substituted N-phenylhydroxylamines
08/26/2014US8815924 Heterocyclic carbonyl compounds
08/26/2014US8815910 Compounds and methods for inhibiting phosphate transport
08/26/2014US8815871 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
08/26/2014CA2653039C Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 256